Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC)
0.1.20 - Build CI United States of America flag

Pharmaceutical Quality Submissions to Food & Drug Administration (PQ/CMC), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.1.20 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc/ and changes regularly. See the Directory of published versions

ValueSet: EVMPD Substance Classification (Experimental)

Official URL: http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/evmpd-substance-classification Version: 0.1.20
Draft as of 2024-03-04 Computable Name: EVMPDSubstanceClassification

EudraVigilance eXtended Medicinal Product Dictionary (XEVMPD) substance classes

References

Logical Definition (CLD)

  • Include these codes as defined in http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummy
    CodeDisplay
    1Chemical
    17Mixture
    2Nucleic Acid
    3Polymer
    4Protein - Other
    5Protein - Vaccine
    7Structurally Diverse Substance - Immunoglobulin
    6Structurally Diverse Substance - Vaccine
    10Structurally Diverse Substance - Allergen
    11Structurally Diverse Substance - Cell therapy
    9Structurally Diverse Substance - Herbal
    12Structurally Diverse Substance - Other
    8Structurally Diverse Substance - Blood derived

 

Expansion

Expansion based on codesystem Dummy EMA Codesystem v0.1.20 (CodeSystem)

This value set contains 13 concepts.

CodeSystemDisplay
  1http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyChemical
  17http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyMixture
  2http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyNucleic Acid
  3http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyPolymer
  4http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyProtein - Other
  5http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyProtein - Vaccine
  7http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Immunoglobulin
  6http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Vaccine
  10http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Allergen
  11http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Cell therapy
  9http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Herbal
  12http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Other
  8http://hl7.org/fhir/us/pq-cmc-fda/CodeSystem/cmc-ema-dummyStructurally Diverse Substance - Blood derived

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code